Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 39, 2004 - Issue 2
Submit an article Journal homepage
9
Views
6
CrossRef citations to date
0
Altmetric
Article

Histological findings, genotype distribution and percentage of patients fulfilling the treatment criteria among patients with chronic hepatitis C virus infection in a single Swedish centre

A. Hollander Division of Infectious Diseases, Dept. of Medicine and the Division of Pathology, Dept. of Laboratory Medicine, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden
,
H. Glaumann Division of Infectious Diseases, Dept. of Medicine and the Division of Pathology, Dept. of Laboratory Medicine, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden
&
O. Weiland Division of Infectious Diseases, Dept. of Medicine and the Division of Pathology, Dept. of Laboratory Medicine, Karolinska Institute at Huddinge University Hospital, Stockholm, SwedenCorrespondenceola.weiland@medhs.­ki.se
Pages 164-167 | Received 25 Aug 2003, Accepted 17 Oct 2003, Published online: 08 Jul 2009

References

  • Nosbaum J, Pol S, Nalpas B, Landais P, Berthelot P, Bre’chot C, and the Collaboratory Study Group. Hepatitis C virus type 1b infection in France and Italy. Ann Int Med 1995;122: 161–8.
  • Westin J, Lindh M, Lagging LM, Norkrans G, Wejstal R. Chronic hepatitis C in Sweden: genotype distribution over time in different epidemiological settings. Scand J Infect Dis 1999;31: 355–8.
  • Weiland O, Braconier J, Frydén A, Norkrans G, Reichard O, Uhnoo I, and the Swedish Hepatitis Study Group. Influence of pretreatment viral load and genotype, ALT and virological response week 12, and length of interferon alfa treatment on sustained virological outcome in patients with chronic hepatitis C infection. Scand J Infect Dis 1999;31: 115–8.
  • Poynard T, Marcelin P, Lee S, Niederau C, Minuk G, Ideo G, et al, for the International Hepatitis Interventional Therapy Group. Randomised trial of interferon alfa-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352: 1426–32.
  • McHutchison J, Gordon S, Schiff E, Schiffman M, Lee W, Rustgi V, et al, for the Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339: 1485–92.
  • Weiland O. Interferon and ribavirin combination therapy: indications and schedules. Geneva: Forum; 2000;10:22–8.
  • Wejstal R, Fischler B, Glaumann H, Norkrans G, Reichard O, Sonnerborg A, et al. Chronic hepatitis C—Swedish experts’ meeting recommends combination treatment. Scand J Infect Dis 2000;32:465–70.
  • Anonymous. Consensus Statement, EASL International Consensus Conference on hepatitis C. J Hepatology 1999;30:956–61.
  • Manns M, McHutchison J, Gordon S, Rustgi V, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial [In Process Citation]. Lancet 2001;358 (9286):958–65.
  • Fried M, Shiffman M, Reddy K, Smith C, Marinos G, Goncales F, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection [In Process Citation]. N Engl J Med 2002;347: 975–82.
  • Anonymous. NIH consensus development conference statement: management of hepatitis C 2002 (June 10–12, 2002). Hepatology 2002;36 Suppl 1:S3–S20.
  • Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996;34:2259–66.
  • Yun Z, Lara C, Johansson B, Lorenzana RI, Sonnerborg A. Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences. J Med Virol 1996;49: 155–60.
  • Schvarcz R, Glaumann H, Reichard O, Weiland O. Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C. J Viral Hepat 1999;6:237–42.
  • Seeff L. Natural history of hepatitis C. Hepatology 1997;26 Suppl 1:21S–8S.
  • Wejstål R, Alaeus A, Fischler B, Reichard O, Uhnoo I, Weiland O. Chronic hepatitis C: updated Swedish consensus. Scand J Infect Dis 2003;35:445–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.